NDC 65219-332 - Idacio
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 65219-332
- Package NDCs from labels
- 65219-332-95
- Manufacturer
- Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Merck Serono SPA
- Effective date
- 2026-01-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Idacio - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Merck Serono SPA | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Merck Serono SPA | 2026-01-30 | HUMAN PRESCRIPTION DRUG LABEL |
| adalimumab - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Merck Serono SPA | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Merck Serono SPA | 2026-01-08 | HUMAN PRESCRIPTION DRUG LABEL |
| IDACIO - Fresenius Kabi USA, LLC | Merck Serono S.A. | Fresenius Kabi USA, LLC | Merck Serono S.A. | 2024-10-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65219-332-95 | Idacio | 1 in 1 POUCH | SWAB | 2 | 0.75 g | 7 |
| 65219-332-95 | Idacio | 1 in 1 POUCH | SWAB | 2 | 0.75 g | 7 |
| 65219-332-95 | Adalimumab-aacf | 1 in 1 POUCH | SWAB | 2 | 0.75 g | 6 |
| 65219-332-95 | Adalimumab-aacf | 1 in 1 POUCH | SWAB | 2 | 0.75 g | 6 |
| 65219-332-95 | IDACIO | 1 in 1 POUCH | SWAB | 2 | 0.75 g | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 65219-332 | ADALIMUMAB-AACF (ADALIMUMAB) KIT [FRESENIUS KABI USA, LLC] | 5 | Unmatched | 20240826_2488b0bc-7b8f-4cc8-91ea-48e7ea5e8915.zip |
| 65219-332 | IDACIO (ADALIMUMAB-AACF) KIT [FRESENIUS KABI USA, LLC] | 5 | Unmatched | 20250110_43de75ac-1a37-4609-9edd-68bda2448a47.zip |
| 65219-332 | IDACIO (ADALIMUMAB-AACF) KIT [FRESENIUS KABI USA, LLC] | 1 | Unmatched | 20241209_08dbaffe-9d05-43cf-b24b-b44ade8685fc.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 70% | ISOPROPYL ALCOHOL | ADUSA Distribution, LLC | f340dd7e-6412-4621-a818-2592ca78d0f2 | 2026-06-23 | Warnings, Adverse reactions | ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | ADUSA Distribution, LLC | d95a9736-345b-4b7e-9b24-23edb3cbf7e8 | 2026-06-23 | Warnings, Adverse reactions | ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | ADUSA Distribution, LLC | 7e066163-6629-43ad-b0b8-09c16fe94a0d | 2026-06-23 | Warnings, Adverse reactions | ND2M416302 |
| Bacteriostatic Water | BACTERIOSTATIC WATER | Fujian Genohope Biotech Ltd. | 54f66b82-c9e5-a2bc-e063-6394a90adbbc | 2026-06-23 | 059QF0KO0R | |
| Isopropyl Rubbing Alcohol 70 | ISOPROPYL ALCOHOL | Delon Laboratories (1990) Ltd. | fb481568-0c51-421f-9b73-adb4c84645aa | 2026-06-22 | Warnings | ND2M416302 |
| Medline | ISOPROPYL ALCOHOL | Medline Industries, LP | 495076e9-3187-6bfa-e063-6394a90a01f5 | 2026-06-22 | Warnings | 797544 ND2M416302 |
| Rohto Cool Relief | NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80 | The Mentholatum Company | dc8f1ff3-87ae-47ca-815f-5a0e34f8cf30 | 2026-06-19 | Warnings | 6OZP39ZG8H |
| ABRILADA | ADALIMUMAB-AFZB | A-S Medication Solutions | 79943fe6-1249-4074-9aed-c53937820d0f | 2026-06-18 | Boxed warning, Warnings, Adverse reactions | 797544 |
| Isopropyl alcohol 91 percent | ISOPROPYL ALCOHOL | P & L Development, LLC | fcda76cb-63c4-4e81-9e0a-13be506a8150 | 2026-06-17 | Warnings | ND2M416302 |
| Humalog | INSULIN LISPRO | Eli Lilly and Company | c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f | 2026-06-16 | Warnings, Adverse reactions | 059QF0KO0R |
| 0.9% Sodium Chloride Saline Solution | SODIUM CHLORIDE | Yunqi Cosmetics (Shenzhen) Co., Ltd | 546af257-dbd1-11fc-e063-6394a90a8e0a | 2026-06-16 | Warnings | 451W47IQ8X |
| Zolgensma | ONASEMNOGENE ABEPARVOVEC-XIOI | Novartis Innovative Technologies Inc. | 68cd4f06-70e1-40d8-bedb-609ec0afa471 | 2026-06-16 | Boxed warning, Warnings, Adverse reactions | 797544 |
| Skyrizi | RISANKIZUMAB-RZAA | AbbVie Inc. | 7148c8eb-b39e-e20a-6494-a6df82392858 | 2026-06-15 | Warnings, Adverse reactions | 797544 |
| BM BM68 DROPS | ARGENTUM NIT, BARYTA CARB., DULCAMARA, GELSEMIUM, KALI BROM, NAT MUR, CAUSTICUM | BM Private Limited | 53f9c99a-0f20-0358-e063-6394a90af4e0 | 2026-06-15 | Warnings | 451W47IQ8X |
| BM BM68 | ARGENTUM NIT, BARYTA CARB, DULCAMARA, GELSEMIUM, KALI BROM, NAT MUR, CAUSTICUM | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5448c76a-2ecb-9402-e063-6294a90a6ad7 | 2026-06-15 | Warnings | 451W47IQ8X |
| BM BIO28 ALCOHOL | CALC SULPH, CALC FLUOR, CALC PHOS, FERR PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT PHOS, NAT SULPH, NAT MUR, SILICEA | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 544b66c4-49df-556f-e063-6394a90af3ed | 2026-06-15 | Warnings | 451W47IQ8X |
| 70% | ISOPROPYL ALCOHOL | Meijer, Inc. | 7b1f93ff-5eeb-4da1-8f02-7c47d713689a | 2026-06-15 | Warnings, Adverse reactions | ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | Meijer, Inc. | 531cea18-9609-4d78-876d-3ba5d2d1e16f | 2026-06-15 | Warnings, Adverse reactions | ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | Meijer, Inc. | b0d302c2-58a0-4c3e-9c4a-fd34de40c034 | 2026-06-15 | Warnings, Adverse reactions | ND2M416302 |
| Male Support | AGNUS CASTUS, AURUM METALLICUM, BENZOICUM ACIDUM, BRYONIA (ALBA), BUFO RANA, CALADIUM SEGUINUM, CHIMAPHILA UMBELLATA, CLEMATIS ERECTA, CONIUM MACULATUM, CORTISONE ACETICUM, HYPOTHALAMUS SUIS, KALI ARSENICOSUM, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, PROSTATE (SUIS), RHODODENDRON CHRYSANTHUM, SABAL SERRULATA, SELENIUM METALLICUM, SEPIA, TESTOSTERONE, THUJA OCCIDENTALIS | Deseret Biologicals, Inc. | 29cefc89-3bb6-484e-84ab-116b5827a4c3 | 2026-06-15 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.